$38.59 +0.92 (%) Baxter International Inc - NYSE

Aug. 27, 2015 | 04:00 PM

Partner Headlines

  1. Baxalta Vs. AbbVie: Biopharma Spin-Off Battle

    GuruFocus | Aug. 20, 2015 | 12:01PM EST
  2. Dan Loeb Is Still Bullish On Amgen, Allergan and Dow Chemical

    Benzinga | Aug. 18, 2015 | 16:33PM EST
  3. Baxter and Water Street Announce FDA Approval of CEFAZOLIN 2 Gram Premix

    Benzinga | Aug. 14, 2015 | 09:00AM EST
  4. Scott Black Sells Stakes in 10 Companies

    GuruFocus | Aug. 10, 2015 | 19:37PM EST
  5. Dan Loeb's Latest Activist Target Baxter International

    GuruFocus | Aug. 6, 2015 | 18:41PM EST
  6. Vanguard Health Care Fund Buys Two New Stakes in Second Quarter

    GuruFocus | Aug. 6, 2015 | 18:14PM EST
  7. Hedge Fund Action: Dan Loeb Likes Baxter, Gabelli Prefers Global Sources

    Benzinga | Aug. 5, 2015 | 17:23PM EST
  8. Baxalta Baxter 13D Filing Shows 3rd Point Stake Of 7%, 3rd Point Seeking 2 Board Seats

    Benzinga | Aug. 5, 2015 | 13:39PM EST
  9. Undervalued Baxalta Shares Target of Acquisition by Shire Plc

    GuruFocus | Aug. 5, 2015 | 11:21AM EST
  10. Shire Spurned For Baxalta Bid

    IBD | Aug. 4, 2015 | 18:47PM EST
  11. Mid-Day Market Update: Tuesday's Top 10 Volume Stocks

    Benzinga | Aug. 4, 2015 | 14:35PM EST
  12. Stock Indexes Near Day's Lows; Earnings, Buyouts Stir Medicals

    IBD | Aug. 4, 2015 | 13:25PM EST
  13. Mid-Day Market Update: Tuesday's Movers, China's New Short-Sell Rule, Greece's Stock Exchange

    Benzinga | Aug. 4, 2015 | 13:00PM EST
  14. Shire Offers $30 Billion For Ex-Baxter Unit Baxalta

    IBD | Aug. 4, 2015 | 10:46AM EST
  15. Benzinga's Top Downgrades

    Benzinga | Jul. 7, 2015 | 09:29AM EST
  16. Unusual Call Activity In Baxter

    Benzinga | Jul. 7, 2015 | 08:12AM EST
  17. Benzinga's Top Downgrades

    Benzinga | Jul. 2, 2015 | 09:32AM EST
  18. Baxter Shares Bid Up Ahead Of Spinoff

    IBD | Jun. 25, 2015 | 18:30PM EST
  19. US Stock Futures Surge Ahead Of Jobless Claims

    Benzinga | Jun. 25, 2015 | 08:10AM EST
  20. U.S. FDA Grants Priority Review for MM-398 New Drug Application

    Benzinga | Jun. 25, 2015 | 07:05AM EST
  21. Goldman Sachs Initiates Baxter International With Buy

    Benzinga | Jun. 24, 2015 | 10:50AM EST
  22. Benzinga's Top Initiations

    Benzinga | Jun. 24, 2015 | 09:59AM EST
  23. Baxalta Reports Continued Progress on Phase 1/2 Clinical Trial of BAX335, Investigational Gene Therapy Treatment for Hemophilia B

    Benzinga | Jun. 24, 2015 | 09:01AM EST
  24. Baxter Announces Effectiveness of Baxalta Form 10 Registration Statement

    Benzinga | Jun. 9, 2015 | 17:04PM EST
  25. Baxter and Baxalta Holdings Outline Vision for Accelerated and Sustainable Growth, Showcase Innovation

    Benzinga | May. 18, 2015 | 08:35AM EST
  26. Baxter buying leukemia drugs

    IBD | May. 12, 2015 | 19:01PM EST
  27. Take Steps To Become The Best You

    IBD | Apr. 28, 2015 | 14:41PM EST
  28. Akorn Downgraded, Stock Falls On 'Credibility Gap'

    IBD | Apr. 27, 2015 | 11:26AM EST
  29. Baxter

    IBD | Apr. 23, 2015 | 18:31PM EST
  30. Earnings Scheduled For April 23, 2015

    Benzinga | Apr. 23, 2015 | 04:03AM EST
  31. Cyberonics Soars On Earnings Beat, Tax Inversion Deal

    IBD | Feb. 26, 2015 | 13:58PM EST
  32. To Reinvest or Not Reinvest: That is the Question

    GuruFocus | Feb. 19, 2015 | 09:55AM EST
  33. Best Stock Pick For Long Term Investors

    GuruFocus | Feb. 10, 2015 | 14:40PM EST
  34. Richard Pzena's New Buys

    GuruFocus | Feb. 9, 2015 | 14:43PM EST
  35. Richard Pzena's 5 New Q4 Stock Buys

    GuruFocus | Feb. 7, 2015 | 00:56AM EST
  36. Baxter Int'l

    IBD | Jan. 29, 2015 | 18:38PM EST
  37. Earnings Scheduled For January 29, 2015

    Benzinga | Jan. 29, 2015 | 04:45AM EST
  38. Baxter Offers Yield In Hot Medical Products Group

    IBD | Jan. 16, 2015 | 17:47PM EST
  39. What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts

    Benzinga | Jan. 9, 2015 | 12:53PM EST
  40. Spinal Products Firm NuVasive Ripe For Expansion

    IBD | Jan. 8, 2015 | 15:17PM EST
  41. What Investors Should Expect From Rockwell Medical's Next FDA Decision

    Benzinga | Jan. 7, 2015 | 16:22PM EST
  42. Pete Najarian's Picks For 2015: Citigroup, Foot Locker And More

    Benzinga | Jan. 6, 2015 | 17:20PM EST
  43. What Investors Are Looking for After Seeing Unusual Options Activity In Halozyme

    Benzinga | Jan. 6, 2015 | 12:15PM EST
  44. Inogen Powers Up Medical Products Stocks With Oxygen

    IBD | Jan. 5, 2015 | 16:37PM EST
  45. Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment for Von Willebrand Disease

    Benzinga | Dec. 22, 2014 | 09:00AM EST
  46. Baxter Reports Filing of Form 10 Registration Statement Related to Planned Spinoff of Biopharma Unit

    Benzinga | Dec. 10, 2014 | 17:16PM EST
  47. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus | Dec. 9, 2014 | 10:50AM EST
  48. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD | Dec. 4, 2014 | 16:47PM EST
  49. I think Zimmer Will Outperform S&P 500 Performance

    GuruFocus | Dec. 4, 2014 | 10:06AM EST
  50. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus | Nov. 19, 2014 | 12:37PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!